AVE 33.3% 0.2¢ avecho biotechnology limited

Ann: Appendix 3B-POH.AX, page-44

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 5,799 Posts.
    lightbulb Created with Sketch. 737
    Thanks for the information HT.

    However Directors’ options will not be subject to share price performance vesting conditions.

    So to be clear, the options are not share price dependant.
    So are they dependant on anything (apart from shareholder vote)?
    Otherwise if not, if they are just in place, by desire of the board and not performance linked, then it must be in place to ensure adequate compensation for losing positions from a takeover.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(33.3%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.3¢ 0.3¢ 0.2¢ $2.565K 874.4K

Buyers (Bids)

No. Vol. Price($)
29 40547400 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 39021116 27
View Market Depth
Last trade - 15.59pm 12/11/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.